GeneReach Biotechnology Market Cap

GeneReach Biotechnology has a market cap or net worth of 1.11 billion as of April 29, 2026. Its market cap has decreased by -16.67% in one year.

Market Cap

1.11B

Enterprise Value

1.05B

Revenue

232.74M

Ranking

n/a

PE Ratio

n/a

Stock Price

19.30

Market Cap Chart

Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.11B, a decrease of -13.10%. That is a compound annual growth rate of -1.04%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	1.13B	4.06%
Dec 31, 2025	1.08B	-34.10%
Dec 31, 2024	1.65B	-27.38%
Dec 29, 2023	2.27B	-25.28%
Dec 30, 2022	3.03B	-20.04%
Dec 30, 2021	3.79B	-27.82%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BiOptic	1.20B
Holy Stone Healthcare	1.20B
Level Biotechnology	1.09B
Taiwan Advance Bio-Pharmaceutical	1.07B
Lukas Biomedical	1.01B
TCI GENE	1.01B
Abnova (Taiwan)	1.35B
Meribank Biotech	1.36B

Market Cap Rankings